MATSUYAMA Masashi
- Articles
- Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease
Matsuyama Masashi; Suzuki Takeshi; Tsuboi Hiroto; Ito ...
INTERNAL MEDICINE/46(11)/pp.771-774, 2007-01 - Activation of murine invariant NKT cells promotes susceptibility to candidiasis by IL-10-induced modulation of phagocyte antifungal activity
Haraguchi Norihiro; Kikuchi Norihiro; Morishima Yuko; ...
European Journal of Immunology/46(7)/pp.1691-1703, 2016
- Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease